Opportunity Information: Apply for PAR 12 005
Apply for PAR 12 005
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "National Cancer Institute Program Project (P01) Applications" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control.
- This funding opportunity was created on Aug 7, 2013 and posted on Oct 21, 2011.
- Applicants must submit their applications by Aug 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: For profit organizations other than small businesses State governments Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Native American tribal governments (Federally recognized) Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments Independent school districts Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), offered this funding opportunity to support investigator-initiated Program Project (P01) grants. The central purpose of the announcement is to fund large, coordinated research programs that bring together multiple related projects under one umbrella. These applications can cover essentially any major area of cancer research, including cancer biology, detection and diagnosis, treatment, cause and prevention, and cancer control. The opportunity is designed to be broad and flexible, meaning the research can be basic laboratory science, translational work that moves findings toward clinical use, clinical studies involving patients, and/or population-based research focused on communities and public health outcomes.
A defining feature of this P01 mechanism is the required structure: each application must include at least three distinct component projects. Those projects cannot be a loose collection of unrelated studies; they must be clearly connected through a shared central theme, common focus, or an overall objective that ties the whole program together. In practice, this mechanism is meant for teams that can justify why a coordinated, multi-project approach is necessary and why the projects are stronger together than they would be if submitted as separate, independent grants. Although the provided summary does not list specific review criteria, P01 programs are typically expected to show synergy, clear scientific leadership, and a coherent strategy for how the component projects collectively advance the overall cancer research goal.
Administratively, the opportunity was categorized as a discretionary grant program and was associated with multiple CFDA (Catalog of Federal Domestic Assistance) numbers that map to different domains of cancer research: 93.393 (Cancer Cause and Prevention Research), 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), 93.396 (Cancer Biology Research), and 93.399 (Cancer Control). The announcement explicitly states that cost sharing or matching was not required, which generally means applicants did not need to commit non-federal funds as a condition of receiving the award.
Eligibility was expansive across U.S.-based organizations and government entities. Eligible applicants included public and private institutions of higher education, nonprofit organizations (both with and without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), and multiple levels of government such as state, county, city or township governments, special district governments, independent school districts, and public housing authorities or Indian housing authorities. The eligibility language also highlighted a wide set of institution types and community-based organizations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and certain tribal entities (including tribal organizations and tribal governments that are not federally recognized, as specified in the notice). Federal agencies were also listed as eligible. At the same time, the FOA made an important distinction for international participation: non-U.S. (foreign) institutions were not eligible to apply as the primary applicant organization. However, non-U.S. components of U.S. organizations could participate, and foreign components were allowed as defined under NIH policy, which typically means a U.S. applicant can include part of the research effort being performed outside the United States when appropriately justified and compliant with NIH rules.
Key dates in the record indicate the FOA was posted on October 21, 2011, and it was later archived in 2013 (archive date listed as September 7, 2013). The dataset also shows multiple closing-date fields (an original closing date of January 7, 2015, and a current closing date of August 7, 2013), reflecting that the opportunity record was ultimately closed and archived. The official announcement was hosted through the NIH Grants Guide (linked in the source data), and NIH provided technical contact points for access or linking issues through the NIH Office of Extramural Research (OER) webmaster email.
Frequently Asked Questions (FAQs)
1) What agency is offering this grant opportunity?
This funding opportunity was offered by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH).
2) What type of grant mechanism is this?
This opportunity supports investigator-initiated Program Project (P01) grants. The P01 mechanism is intended for large, coordinated research programs made up of multiple related projects organized under one overall program.
3) What is the central purpose of the P01 Program Project funding?
The central purpose is to fund large, coordinated cancer research programs that combine multiple related component projects under a single umbrella, tied together by a shared theme, focus, or overall objective.
4) What areas of cancer research can be proposed under this opportunity?
Applications can cover essentially any major area of cancer research, including cancer biology; detection and diagnosis; treatment; cause and prevention; and cancer control.
5) What kinds of research approaches are allowed (basic, translational, clinical, population-based)?
The opportunity is described as broad and flexible. Proposed research may include basic laboratory science, translational research moving findings toward clinical use, clinical studies involving patients, and/or population-based research focused on communities and public health outcomes.
6) How many component projects are required in a P01 application?
Each P01 application must include at least three distinct component projects.
7) Can the component projects be unrelated as long as they are all about cancer?
No. The component projects cannot be a loose collection of unrelated studies. They must be clearly connected through a shared central theme, common focus, or an overall objective that ties the entire program together.
8) Why does the FOA emphasize coordination and a shared theme?
The P01 mechanism is meant for teams that can justify why a coordinated, multi-project approach is necessary and why the projects are stronger together than they would be if submitted as separate, independent grants.
9) Does the provided summary list specific review criteria for applications?
The provided summary does not list specific review criteria. However, P01 programs are typically expected to demonstrate synergy across projects, clear scientific leadership, and a coherent strategy for how the component projects collectively advance the overall cancer research goal.
10) What CFDA numbers are associated with this opportunity?
This opportunity is associated with multiple CFDA numbers representing different cancer research domains: 93.393 (Cancer Cause and Prevention Research), 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), 93.396 (Cancer Biology Research), and 93.399 (Cancer Control).
11) Is cost sharing or matching required?
No. The announcement explicitly states that cost sharing or matching was not required, meaning applicants generally did not need to commit non-federal funds as a condition of receiving the award.
12) What types of organizations are eligible to apply?
Eligibility is broad across U.S.-based organizations and certain government entities. Eligible applicants include public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); and for-profit organizations (including small businesses and other for-profits).
13) Are government entities eligible applicants?
Yes. Eligible applicants include multiple levels of government such as state, county, city or township governments; special district governments; independent school districts; and public housing authorities or Indian housing authorities.
14) Are minority-serving institutions and community-based organizations included in eligibility?
Yes. The eligibility language explicitly includes a wide set of institution types and community-based organizations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations.
15) Are U.S. territories or possessions included as eligible applicants?
Yes. The eligibility language highlights U.S. territories or possessions among eligible entities.
16) Are tribal entities eligible?
Yes. The eligibility language includes certain tribal entities, including tribal organizations and tribal governments that are not federally recognized, as specified in the notice.
17) Are federal agencies eligible to apply?
Yes. Federal agencies were listed as eligible applicants in the provided information.
18) Can a non-U.S. (foreign) institution apply as the primary applicant?
No. Non-U.S. (foreign) institutions were not eligible to apply as the primary applicant organization under this announcement.
19) Can foreign components participate if the primary applicant is U.S.-based?
Yes. The opportunity indicates that non-U.S. components of U.S. organizations could participate, and foreign components were allowed as defined under NIH policy. This generally means a U.S. applicant may include part of the research effort being performed outside the United States when appropriately justified and compliant with NIH rules.
20) When was the funding opportunity posted?
The FOA record indicates it was posted on October 21, 2011.
21) Has this opportunity been archived or closed?
Yes. The record indicates the opportunity was archived in 2013, with an archive date listed as September 7, 2013. The dataset also reflects that the opportunity record was ultimately closed and archived.
22) Why do the dates show more than one closing date?
The dataset shows multiple closing-date fields (including an original closing date of January 7, 2015, and a current closing date of August 7, 2013). Based on the record description, this reflects that the opportunity was ultimately closed and archived, and the dataset preserved more than one closing-date value.
23) Where was the official announcement hosted?
The official announcement was hosted through the NIH Grants Guide, as indicated by the source data.
24) Who is listed as a technical contact for access or linking issues?
NIH provided technical contact points for access or linking issues through the NIH Office of Extramural Research (OER) webmaster email, as noted in the source data.
25) How is this opportunity categorized administratively?
The opportunity was categorized as a discretionary grant program.
Browse more opportunities from the same category: Education Health
Next opportunity: Fiscal Year 2012 Basic Research Initiative (BRI)
Previous opportunity: NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44) Apply for RFA CA 12 001 Funding Number: RFA CA 12 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi Site Cancer Trials (R01) Apply for PA 12 013 Funding Number: PA 12 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi Site Cancer Trials (R21) Apply for PA 12 014 Funding Number: PA 12 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Shared Instrumentation Grant Program (S10) Apply for PAR 12 017 Funding Number: PAR 12 017 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Midcareer Investigator Award in Mouse Pathobiology and Comprehensive Phenotyping Research (K26) Apply for PAR 12 021 Funding Number: PAR 12 021 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Practical Interventions to Improve Medication Adherence in Primary Care (R21) Apply for PA 12 023 Funding Number: PA 12 023 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Lasker Clinical Research Scholars Program (Si2) Apply for RFA OD 12 001 Funding Number: RFA OD 12 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Application of Genomic Advances to Wound Repair (R21) Apply for RFA NR 12 003 Funding Number: RFA NR 12 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Application of Genomic Advances to Wound Repair (R01) Apply for RFA NR 12 002 Funding Number: RFA NR 12 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01) Apply for PA 12 024 Funding Number: PA 12 024 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Small Grants Program for Cancer Epidemiology (R03) Apply for PAR 12 039 Funding Number: PAR 12 039 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Research to Advance Vaccine Safety (R01) Apply for PA 12 037 Funding Number: PA 12 037 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research to Advance Vaccine Safety (R21) Apply for PA 12 038 Funding Number: PA 12 038 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| International Research Collaboration on Drug Abuse and Addiction Research (R01) Apply for PA 12 040 Funding Number: PA 12 040 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R21) Apply for PA 12 041 Funding Number: PA 12 041 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| International Research Collaboration on Drug Abuse and Addiction Research (R03) Apply for PA 12 042 Funding Number: PA 12 042 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Limited Competition Competitive Revision for Technology Development within Biomedical Technology Research Centers (P41) Apply for PAR 12 046 Funding Number: PAR 12 046 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Cancer Education Grants Program (R25) Apply for PAR 12 049 Funding Number: PAR 12 049 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Palliative Care and End of Life in People Living with HIV/AIDS(R01) Apply for RFA NR 12 004 Funding Number: RFA NR 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Palliative Care and End of Life in People Living with HIV/AIDS (R21) Apply for RFA NR 12 005 Funding Number: RFA NR 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.